Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on October 30, 2019, 10:49:10 am
-
An investigation two-part vaccine was unable to prevent chronic hepatitis C virus (HCV) infection in a clinical trial, though it did appear to stimulate T-cell activity against the virus, researchers reported at the IDWeek 2019 conference this month in Washington, DC.
Around a quarter of people who acquire HCV are able to clear the virus spontaneously without treatment and never develop chronic, or long-term, infection lasting more than six months. Among those who do develop chronic infection, new direct-acting antivirals can cure almost everyone with two or three months of treatment.
Read more...
https://www.hepmag.com/article/experimental-hepatitis-c-vaccine